MalarVx, Inc.
Home
ABOUT
The challenge
The Disease – Malaria
The Team
R&D
Vaccine Development
In vitro mosquito-stages
Pipeline
Publications
News
Contact
Citations
Life Science Innovation Northwest 2026
Marion Avril
June 16, 2026
12:28 am
In Seattle, WA, USA, April 21st and 22nd 2026, MalarVx's CEO James Davie and Program Director Dr Avril attended the Life Science Innovation NorthWest 2026 conference.
Category :
Business
Previous
ASTMH 2025, Toronto, Ontario, Canada